1. Alkon C. 2015 Doctors Unwilling to Trust Similarity of Biosimilars Oncology Business News http://www.onclive.com/publications/oncology-business-news/2015/june-2015/doctors-unwilling-to-trust-similarity-of-biosimilars/1
2. Nonclinical aspects of biosimilar development: practical considerations from an industry perspective;Baldrick;Regul. Rapporteur,2012
3. Non-clinical safety evaluation of novel vaccines and adjuvants, new strategies;Brennan;Vaccine,2005
4. Preclinical Safety Evaluation of Biopharmaceuticals